Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0038 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0023 | 0.2407 | 0.2407 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0038 | 1 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0038 | 1 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0038 | 1 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0038 | 1 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0033 | 0.7743 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0019 | 0 | 0.5 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0038 | 1 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0038 | 1 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0019 | 0.0151 | 0.0151 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0038 | 1 | 0.5 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0038 | 1 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0038 | 1 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0038 | 1 | 0.5 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0038 | 1 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0038 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0038 | 1 | 1 |
Leishmania major | p450 reductase, putative | 0.0038 | 1 | 1 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0038 | 1 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0038 | 1 | 1 |
Trypanosoma cruzi | p450 reductase, putative | 0.0038 | 1 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0033 | 0.7743 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0038 | 1 | 1 |
Chlamydia trachomatis | sulfite reductase | 0.0023 | 0.2407 | 0.5 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0038 | 1 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0019 | 0 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0038 | 1 | 0.5 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0038 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
I50 (functional) | = 0.000000003 M | In vitro concentration required for 50% inhibition of swelling of cat cerebrocortical slices | ChEMBL. | 3701792 |
I50 (functional) | = 0.000000006 M | In vitro concentration required for 50% inhibition of swelling of cat cerebrocortical slices | ChEMBL. | 3701792 |
logD (ADMET) | = 83 % | Partition coefficient (logD7.4) | ChEMBL. | 3701792 |
logD (ADMET) | = 83 % | Partition coefficient (logD7.4) | ChEMBL. | 3701792 |
logD (ADMET) | = 91 % | Partition coefficient (logD7.4) | ChEMBL. | 3701792 |
logD (ADMET) | = 91 % | Partition coefficient (logD7.4) | ChEMBL. | 3701792 |
pKa | = 3.8 | Dissociation constant (pKa) (determined in 30% EtOH) | ChEMBL. | 3701792 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.